CYP2E1 and alcoholic fatty liver disease: In conclusion, the treatment of alcohol fatty liver disease with PCP mainly exerted anti-inflammatory effects by inhibiting CYP2E1 to attenuate the release of endotoxin and inhibiting MyD88/TLR4/NF-κB signaling pathway.